STYK1 and neoplasm: The results of in vivo imaging revealed that 4 weeks after tail vein injection of tumor cells, mice harboring STYK1 overexpressing SW900 cells had more metastatic sites (Figure 4A) and emitted more photons than mice injected with wild-type cells (Figure 4B).